{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:59:29Z","timestamp":1771559969926,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.schres.2016.11.009","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T04:18:38Z","timestamp":1479788318000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine"],"prefix":"10.1016","volume":"183","author":[{"given":"DPJ","family":"Osborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Marston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MB","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2016.11.009_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.schres.2016.11.009_bb0010","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform. Prim. Care"},{"issue":"6732","key":"10.1016\/j.schres.2016.11.009_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.schres.2016.11.009_bb0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","article-title":"Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study","volume":"170","author":"Crump","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.11.009_bb0025","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/pds.1770","article-title":"Creating medical and drug code lists to identify cases in primary care databases","volume":"18","author":"Dave","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.schres.2016.11.009_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.schres.2009.12.029","article-title":"Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study","volume":"117","author":"De Hert","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.11.009_bb0035","doi-asserted-by":"crossref","first-page":"f6409","DOI":"10.1136\/bmj.f6409","article-title":"Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research","volume":"347","author":"Freemantle","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2016.11.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082365","article-title":"Recording of severe mental illness in United Kingdom primary care, 2000\u20132010","volume":"8","author":"Hardoon","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.schres.2016.11.009_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20298","article-title":"Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records","volume":"15","author":"Hayes","year":"2016","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.11.009_bb0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.schres.2013.07.043","article-title":"Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up","volume":"150","author":"Kiviniemi","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.11.009_bb0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2016.11.009_bb0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0895-4356(94)00137-F","article-title":"The VAMP research multi-purpose database in the UK","volume":"48","author":"Lis","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2016.11.009_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/247486","article-title":"Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database","author":"Murray-Thomas","year":"2013","journal-title":"Cardiovasc. Psychiatry Neurol."},{"issue":"2","key":"10.1016\/j.schres.2016.11.009_bb0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archpsyc.64.2.242","article-title":"Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's general practice research database","volume":"64","author":"Osborn","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.11.009_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamapsychiatry.2014.2133","article-title":"Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program","volume":"72","author":"Osborn","year":"2014","journal-title":"JAMA Psychiat."},{"issue":"2","key":"10.1016\/j.schres.2016.11.009_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/pds.2213","article-title":"National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom","volume":"21","author":"Prah","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2016.11.009_bb0085","series-title":"Stata Statistical Software: Release 13","author":"StataCorp","year":"2013"},{"key":"10.1016\/j.schres.2016.11.009_bb0090","author":"The Health Improvement Network"},{"issue":"9690","key":"10.1016\/j.schres.2016.11.009_bb0095","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.schres.2016.11.009_bb0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/schbul\/sbu164","article-title":"Antipsychotic treatment and mortality in schizophrenia","volume":"41","author":"Torniainen","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2016.11.009_bb0105","series-title":"Inequalities in Health in the Northern Region. Newcastle Upon Tyne: Northern Regional Health Authority and University of Bristol","author":"Townsend","year":"1986"},{"key":"10.1016\/j.schres.2016.11.009_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2009.05.018","article-title":"Influence of antipsychotics on mortality in schizophrenia: systematic review","author":"Weinmann","year":"2009","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416305023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416305023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T09:56:36Z","timestamp":1536227796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416305023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":22,"alternative-id":["S0920996416305023"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.11.009","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}